Sex and Interleukin-6 Are Prognostic Factors for Autoimmune Toxicity Following Treatment With Anti-Ctla4 Blockade

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-018-1467-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Interleukin-4-Independent Acceleration of Cutaneous Leishmaniasis in Susceptible BALB/c Mice Following Treatment With Anti-Ctla4 Antibody

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1999English

Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-Cd20 Therapy

JAMA Neurology
Neurology
2013English

Anti-Interleukin 6 Receptor Antibody Treatment in Rheumatic Disease

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Can We Use Interleukin-1β Blockade for Lung Cancer Treatment?

Translational Lung Cancer Research
Oncology
2018English

Anti-Interleukin-6 Receptor Antibody Reduces Neuropathic Pain Following Spinal Cord Injury in Mice

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

High Neuroticism and Low Conscientiousness Are Associated With Interleukin-6

Psychological Medicine
PsychiatryMental HealthApplied Psychology
2009English

CTLA4 Blockade Increases Th17 Cells in Patients With Metastatic Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2009English

Anti-Inflammatory Panacea? The Expanding Therapeutics of Interleukin-1 Blockade

Current Opinion in Rheumatology
Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy